Searched for:
(1 - 8 of 8)
document
van der Ploeg, C.P.B. (author), Grevinga, M. (author), Eekhout, I. (author), Vlasblom, E. (author), Lanting, C.I. (author), van Minderhout, H.M. (author), Dijk-van der Poel, J. (author), van den Akker-van Marle, M.E. (author), Verkerk, P.H. (author)
Background: Little is known about costs and effects of vision screening strategies to detect amblyopia. Aim of this study was to compare costs and effects of conventional (optotype) vision screening, photoscreening or a combination in children aged 3-6 years. Methods: Population-based, cross-sectional study in preventive child health care in The...
article 2021
document
van der Ploeg, C.P.B. (author), Grevinga, M. (author), Eekhout, I. (author), Vlasblom, E. (author), Lanting, C.I. (author), van Minderhout, H.M. (author), Dijk-van der Poel, J. (author), van den Akker-van Marle, M.E. (author), Verkerk, P.H. (author)
Comment on the article: Costs and effects of conventional vision screening and photoscreening in the Dutch preventive child health care system. We thank professor Simonsz for his comments, since it gives us the opportunity to clarify some of our findings. Indeed, with the price for the photoscreening device of €2.29 per child as calculated in...
article 2021
document
van der Ploeg, C.P.B. (author), Blom, M. (author), Bredius, R.G.M. (author), van der Burg, M. (author), Schielen, P.C.J.I. (author), Verkerk, P.H. (author), van den Akker-van Marle, M.E. (author)
Severe combined immunodeficiency (SCID) is a condition that often results in severe infections and death at young age. Early detection shortly after birth, followed by treatment before infections occur, largely increases the chances of survival. As the incidence of SCID is low, assessing cost-effectiveness of adding screening for SCID to the...
article 2019
document
van der Ploeg, C.P.B. (author), Vlasblom, E. (author), Eekhout, I. (author), Lanting, C.I. (author), Verkerk, P.H. (author), van Dijk-van der Poel, J. (author), van Minderhout, H.M. (author), van den Akker-van Marle, M.E. (author)
public lecture 2018
document
van der Ploeg, C.P.B. (author), Vlasblom, E. (author), Eekhout, I. (author), van Dijk-van der Poel, J. (author), van Minderhout, H.M. (author), van den Akker-van Marle, M.E. (author), Lanting, C.I. (author), Verkerk, P.H. (author)
conference paper 2017
document
van der Ploeg, K. (author), van den Akker-van Marle, E. (author), Brediu, R. (author), Staal, F. (author), van den Burg, M. (author), Verkerk, P. (author)
De minister van VWS is voornemens om de neonatale hielprikscreening met veertien aandoeningen uit te breiden, waaronder severe combined immunodeficiency (SCID). Deze aandoening leidt vaak al kort na geboorte tot ernstige infecties en overlijden op jonge leeftijd. Vroegtijdige ontdekking via screening, gevolgd door behandeling (meestal...
report 2017
document
van der Ploeg, C.P.B. (author), Vlasblom, E. (author), Eekhout, I. (author), van Dijk-van der Poel, J. (author), van Minderhout, H.M. (author), van den Akker-van Marle, M.E. (author), Lanting, C.I. (author), Verkerk, P.H. (author)
Abstract van het Mind the gap! Building bridges to better health for all young people, EUSUHM (European Union for School and University Health and Medicine) congres 2017, Leuven.
article 2017
document
van der Ploeg, C.P.B. (author), van den Akker-van Marle, M.E. (author), Vernooij-van Langen, A.M.M. (author), Elvers, L.H. (author), Gille, J.J.P. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), Loeber, J.G. (author), Triepels, R.H. (author), van der Pal, S.M. (author), Dompeling, E. (author), Pals, G. (author), Gulmans, V.A.M. (author), Oey-Spauwen, M.J.W. (author), Wijnands, Y.H.H.M. (author), Castricum, L.M. (author), Arets, H.G.M. (author), van der Ent, C.K. (author), Tiddens, H.A.W.M. (author), de Rijke, Y.B. (author), Yntema, J.B. (author)
BACKGROUND: Previous cost-effectiveness studies using data from the literature showed that newborn screening for cystic fibrosis (NBSCF) is a good economic option with positive health effects and longer survival. METHODS: We used primary data to compare cost-effectiveness of four screening strategies for NBSCF, i.e. immunoreactive trypsinogen...
article 2015
Searched for:
(1 - 8 of 8)